GigaGen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GigaGen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11152
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GigaGen Inc (GigaGen) is a pre-clinical biotherapeutics company that develops antibody therapies to treat diseases of immune dysregulation. The company discovers and develops monoclonal and polyclonal antibody therapies and T cell therapies derived from immune repertoires. Its single cell sequencing and protein expression platform utilizes the microfluidics, bioinformatics, next generation sequencing, and genetic engineering to mine B and T cell repertoires for full length natively paired antibodies and T cell receptors. GigaGen’s technology platform integrates the cell clonal identity, function, and target binding. The company has collaboration with the academic and biopharmaceutical researchers in the areas of antibody discovery, massively polyclonal natural repertoire antibodies, and cancer repertoire analysis. GigaGen is headquartered in South San Francisco, California, the US.

GigaGen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GigaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GigaGen Inc, Medical Devices Deals, 2012 to YTD 2018 9
GigaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
GigaGen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
GigaGen Raises USD36 Million in Venture Financing 11
Partnerships 12
Grifols and GigaGen Enter into Research Agreement 12
GigaGen and Cellular Therapeutics Enter into Partnership 13
GigaGen Enters into Research Agreement with Novartis 14
Licensing Agreements 15
Trianni Enters into Licensing Agreement with GigaGen 15
Acquisition 16
Grifols Acquires 43.96% Stake in GigaGen for USD35 Million 16
GigaGen Inc – Key Competitors 17
GigaGen Inc – Key Employees 18
GigaGen Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Strategy And Business Planning 20
Jan 23, 2018: GigaGen Announces New Office Space in South San Francisco 20
Government and Public Interest 21
Jan 16, 2018: GigaGen Receives NIH Grant to Develop Production Technology for Recombinant Intravenous Immunoglobulin 21
Product News 22
Dec 19, 2017: GigaGen to Develop Human Antibodies Against 17 Immuno-oncology Targets 22
Feb 05, 2018: Natively Paired Antibodies Are Better: Study by GigaGen in Collaboration with Global Biopharmaceutical Company Describes Novel Approach to Identifying Antibodies with High Therapeutic Potential 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
GigaGen Inc, Pharmaceuticals & Healthcare, Key Facts 2
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GigaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GigaGen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
GigaGen Inc, Medical Devices Deals, 2012 to YTD 2018 9
GigaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
GigaGen Raises USD36 Million in Venture Financing 11
Grifols and GigaGen Enter into Research Agreement 12
GigaGen and Cellular Therapeutics Enter into Partnership 13
GigaGen Enters into Research Agreement with Novartis 14
Trianni Enters into Licensing Agreement with GigaGen 15
Grifols Acquires 43.96% Stake in GigaGen for USD35 Million 16
GigaGen Inc, Key Competitors 17
GigaGen Inc, Key Employees 18

List of Figures
GigaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GigaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GigaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GigaGen Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[GigaGen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Woolworths Ltd (WOW):企業の財務・戦略的SWOT分析
    Woolworths Ltd (WOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alamo Group, Inc.:企業の戦略・SWOT・財務分析
    Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Central Petroleum Ltd (CTP):企業の財務・戦略的SWOT分析
    Summary Central Petroleum Ltd (CPL) operates as an oil and gas company that offers exploration and development services. The company develops, produces, processes and markets hydrocarbons. It operates its oil and gas assets in Amadeus basin, Pedirka basin, Georgina basin, and Wiso basin. CPL’s Amade …
  • SurModics Inc (SRDX):医療機器:M&Aディール及び事業提携情報
    Summary SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed …
  • AAK AB:企業の戦略・SWOT・財務情報
    AAK AB - Strategy, SWOT and Corporate Finance Report Summary AAK AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Red River Valley Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Red River Valley Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Mayne Pharma Group Ltd (MYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Efora Energy Ltd (EEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Efora Energy Ltd (Efora Energy), formerly SacOil Holdings Ltd, a subsidiary of Public Investment Corp Ltd, is an independent oil and gas exploration and production company that acquires, explores, develops and produces hydrocarbon assets in Africa. The company holds a diverse portfolio of as …
  • IRB Infrastructure Developers Ltd:企業の戦略・SWOT・財務情報
    IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report Summary IRB Infrastructure Developers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • STMicroelectronics N.V. (STM)-医療機器分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • Empire Genomics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Empire Genomics LLC (Genomics) is a medical device company that offers clinical molecular diagnostic solutions. The company provides ID labs products, fish probes, BAC clones, and genotyping and circulating tumor cell products. Its ID lab products include cytogenetics media, cytogenetics pro …
  • Central National-Gottesman Inc.:企業の戦略・SWOT・財務情報
    Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report Summary Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Genzyme Corp-医療機器分野:企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …
  • Abbott Vascular Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It …
  • Northern Trust Corporation:企業の戦略・SWOT・財務情報
    Northern Trust Corporation - Strategy, SWOT and Corporate Finance Report Summary Northern Trust Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Koch Industries Inc:企業の戦略的SWOT分析
    Koch Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Qatar Airways Group Q.C.S.C.:企業の戦略・SWOT・財務分析
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Ocugen Inc (OCGN):企業の財務・戦略的SWOT分析
    Summary Ocugen Inc (Ocugen), formerly Histogenics Corp, is a biopharmaceutical company that discovers, develops and commercializes transformative drugs for the treatment of eye diseases. The company’s lead product candidate, OCU300, is a small molecule therapeutic intended for the treatment of ocula …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a biotechnology company developing antibodies to treat cancer by harnessing the immune system. It offers Lumoxiti, a CD22-directed immunotoxin for the treatment of relapsed or refractory hairy cell leukemia (HCL). The company is investigating drugs against …
  • Carmanah Technologies Corporation:企業の戦略的SWOT分析
    Carmanah Technologies Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆